A Deceased Estate Administration Expert creates an online course for Australians facing the executor role
Danielle Phillips is a 2026 Business Elite's TOP 40 honouree and a finalist in four categories at the 2026 AusMumpreneur Awards ADELAIDE, Australia, Aug. 27, 2026 /PRNewswire/ -- Most people prepare a Will, but few prepare the person who will have...
Huawei Recognized as a Leader in Gartner® Magic Quadrant™ for Enterprise Storage Platforms, 2026
Summary Huawei Recognized as a Leader in Gartner® Magic Quadrant™ for Enterprise Storage Platforms, 2026. Huawei OceanStor Data Storage leverages a high-efficiency and unified AI data platform, excellent capacity density and energy efficiency, and...
Luxshare Precision Reports 40.2% Revenue Growth in First Half 2026; Business Mix Supports Margin Expansion
Broad-based growth across consumer electronics, communications and data center, and automotive electronics, supported by targeted investment in AI infrastructure, intelligent vehicles and global delivery capacity DONGGUAN, China, Aug. 28, 2026...
NECA Expands Telehealth Care with New Counselling and Dietitian Support
NeuroEndocrine Cancer Australia strengthens free specialist support for patients, carers, and families affected by neuroendocrine cancer. SYDNEY, Aug. 28, 2026 /PRNewswire/ -- NeuroEndocrine Cancer Australia (NECA) has expanded its national...
Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion
INCHEON, South Korea, Aug. 28, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today announced a rights offering to raise an expected aggregate amount of KRW 3 trillion to fund investments in the company's three-dimensional, long-term growth...
Kazia Therapeutics Limited Announces Proposed Public Offering
SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and...
Kazia Therapeutics Reports 100% Clinical Benefit Rate in Initial Six Patients Treated for Advanced Triple-Negative Breast Cancer
Durable Complete Metabolic Response Ongoing Since November 2025 All Evaluable Patients Demonstrated Reductions in Metastasis-Associated CTC Clusters and Terminally Exhausted T cells, With Median Reductions of 83% and 51% Respectively No...
Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care
MELBOURNE, Australia, Aug. 28, 2026 /PRNewswire/ -- Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer to Australian patients and researchers, reducing...